Cost-Effectiveness Analysis of Somatostatin Receptor Scintigraphy

Journal of Nuclear Medicine

Volumn 37, Issue 6, 1996, Pages 886-892

  Kwekkeboom, D J ^a   Lamberts, S W J ^b   Habbema, J D F ^b   Krenning, E P ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Indium 111 octreotide; Neuroendocrine tumors; Somatostatin receptor imaging

Indexed keywords

DIAGNOSTIC AGENT; DRUG DERIVATIVE; INDIUM; OCTREOTIDE; PENTETIC ACID; SDZ 215 811; SDZ 215-811; SOMATOSTATIN RECEPTOR;

ARTICLE; CARCINOID; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; COST; COST BENEFIT ANALYSIS; ECONOMICS; HUMAN; LUNG TUMOR; MEDULLARY CARCINOMA; NETHERLANDS; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; PARAGANGLIOMA; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SMALL CELL CARCINOMA; THYROID TUMOR;

CARCINOID TUMOR; CARCINOMA, MEDULLARY; CARCINOMA, SMALL CELL; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; HUMANS; INDIUM RADIOISOTOPES; LUNG NEOPLASMS; NETHERLANDS; NEUROENDOCRINE TUMORS; OCTREOTIDE; PANCREATIC NEOPLASMS; PARAGANGLIOMA; PENTETIC ACID; RECEPTORS, SOMATOSTATIN; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0030161550     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Krenning EP, Bakker WH, Breeman WAP, et al. Localization of endocrine-related tumors with radioiodinated analog of somatostatin. Lancet 1989;1:242-244.
2. Kwekkeboom DJ, Krenning KP, Bakker WH, Oei HY, Kooij PPM, Lamberts SWJ. Somatostatin analog scintigraphy in carcinoid tumors. Eur J Nucl Med 1993;20:283-292.
3. Kwekkeboom DJ, Reubi JC, Lamberts SWJ, et al. In vivo somatostatin receptor imaging in medullary thyroid carcinoma. J Clin Endocrinol Metab 1993;76:1413-1417.
4. Kwekkeboom DJ, Van Urk H, Pauw KH, et al. Octreotide scintigraphy for the detection of paragangliomas. J Nucl Mud 1993;34:873-878.
5. Kwekkeboom DJ. Krenning EP, Oei HY, van Eyck CHJ, Lamberts SWJ. Use of radiolabeled somatostatin to localize islet cell tumors. In: Mignon M, Jensen RT (eds). Frontiers of gastro-intestinal research, Vol 23. Endocrine tumors of the pancreas. Karger, New York; 1995;298-308.
6. Kwekkeboom DJ, Kho GS, Lamberts SWJ, Reubi JC, Laissue JA, Krenning EP. The value of octreotide scintigraphy in patients with lung cancer. Eur J Nucl Med 1994;21:1106-1113.
7. 3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993;20:716-731.
8. 111In-pentetreotide for endocrine gastroenteropancreatic tumors. Horm Metab Res 1993;27(suppl):28-35.
9. 1]-octreotide. Acta Oncol 1993;32:783-786.
10. Dörr U, Würstlin S, Frank-Raue K, et al. Somatostatin receptor scintigraphy and magnetic resonance imaging in recurrent medullary thyroid carcinoma: a comparative study. Horm Metab Res 1993;27(suppl):48-55.
11. Som PM, Sacher M, Stollman AL, Biller HF, Lawson W. Common tumors of the parapharyngeal space: refined imaging diagnosis. Radiology 1988;169:81-85.
12. Phelps PD, Cheesman AD. Imaging jugulotympanic glomus tumors. Arch Otolaryngol Head Neck Surg 1990;116:940-945.
13. Hodge KM, Byers RM, Peters LJ. Paragangliomas of the head and neck. Arch Otolaryngol Head Neck Surg 1988;114:872-877.
14. Scherübl H, Bäder M, Fett U, et al. Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumors. Gastroenterology 1993;105:1705-1709.
15. Zimmer T, Ziegler K, Bäder M, et al. Localization of neuroendocrine tumors of the upper gastrointestinal tract. Gut 1994;35:471-475.
16. Joseph K, Stapp J, Reinecke J, et al. Rezeptorszintigraphie bei endokrinen gastroenteropankreatischen tumoren. Dtsch Med Wschr 1992;117:1025-1028.
17. Reynolds JC, Koong SS, Gibril F, et al. In-111 pentetreotide imaging of gastrinomas: comparison with CT, MRI and angiography. J Nucl Med 1995;36:126P.
18. Rösch T, Lightdale CJ, Botet JF, et al. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med 1992;326:1721-1726.
19. Lebtahi R, Cadiol G, Sarda L, et al. Clinical interest of Octreoscan 111 scintigraphy in gastroenteropancreatic endocrine tumors [Abstract]. J Nucl Med 1994;35:96P.
20. Weinel RJ, Neuhaus C, Stapp J, et al. Preoperative localization of gastrointestinal endocrine tumors using somatostatin-receptor scintigraphy. Ann Surg 1993;218:640-645.
21. Lamberts SWJ, Hofland LJ, Koetsveld PM van, et al. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors. Consequences with regard to diagnosis, localization and therapy. J Clin Endocrinol Metab 1990;71:566-574.
22. Leihta T, Meghdadi S, Studnicka M, et al. The role of iodine-123-Tyr-3-octreotide scintigraphy in the staging of small-cell lung cancer. J Nucl Med 1993;34:1397-1402.
23. 111In]pentetreotide, a radiolabeled somatostatin analog. Br J Cancer 1994;69:762-766.
24. Kirsch CM, von Pawel J, Grau I, Tatsch K. Indium-111 pentetreotide in the diagnostic work-up of patients with bronchogenic carcinoma. Eur J Nucl Med 1994;21:1318-1325.